Abstract
Background
The purpose of this study was to analyse less known clinical scenarios associated with idiopathic intracranial hypertension.
Methods
The study involved analysis of magnetic resonance imaging signs of idiopathic intracranial hypertension in patients with spontaneous rhinoliquorrhoea (n = 7), in patients with temporal lobe epilepsy and surgically treated antero-inferior temporal lobe meningo-encephaloceles (n = 15), and in patients who developed clinical signs of idiopathic intracranial hypertension following the treatment of spontaneous intracranial hypotension (n = 7).
Results
Three of six patients with spontaneous rhinoliquorrhoea and six of 15 operated patients with temporal lobe epilepsy due to temporal lobe meningo-encephaloceles showed magnetic resonance imaging signs of idiopathic intracranial hypertension and had a body mass index >30 kg/m2. Rebound high pressure headaches and sings of idiopathic intracranial hypertension occurred in seven of 44 surgically treated spontaneous intracranial hypotension patients.
Conclusions
Magnetic resonance imaging findings should guide the clinician to consider (idiopathic) intracranial hypertension when patients develop spontaneous rhinoliquorrhoea, temporal lobe epilepsy secondary to temporal lobe meningoencephaloceles or high pressure headaches in spontaneous intracranial hypotension. Whether idiopathic intracranial hypertension must be regarded as a differential diagnosis or as a cause, or whether there are common pathophysiological pathways that lead to signs of idiopathic intracranial hypertension in this wider spectrum of disease is the focus of further study.
Keywords: Spontaneous intracranial hypotension, idiopathic intracranial hypertension, rebound intracranial hypertension
Idiopathic intracranial hypertension (IIH) is a headache syndrome associated with elevated intracranial pressure in the absence of a space-occupying lesion and mostly occurs in obese women of childbearing age. Diagnostic criteria include a cerebrospinal fluid (CSF) pressure exceeding 250 mm and that (a) the headache has developed or significantly worsened in temporal relation to the IIH or has led to its discovery and/or (b) that the headache is accompanied by a pulsatile tinnitus and/or papilloedema. 1 Magnetic resonance imaging (MRI) findings include empty sella, distention of the perioptic subarachnoid space, flattening of the posterior sclerae, protrusion of the optic nerve papillae into the vitreous body and transverse sinus stenosis.1–5 Since headaches and/or visual symptoms are not always present, diagnosis of some entities associated with IIH might missed. Such entities are spontaneous rhinoliquorrhoea, antero-inferior temporal lobe meningo-encephaloceles and temporal lobe epilepsy (TLE), as well as rebound intracranial hypertension (RIH) following the treatment of spontaneous intracranial hypotension (SIH).6–13 Here, we analysed clinical and imaging presentations of consecutive patients out of these entities that were treated at our institution. The aim of the study was to describe frequencies of IHH signs on MRI in this wider spectrum of disease and to identify possible common patterns.
Methods
We carried out retrospective analysis of the clinical characteristics and imaging work-up for: (a) patients with spontaneous rhinoliquorrhoea; (b) patients with TLE and operated antero-inferior temporal lobe meningo-encephaloceles; and (c) patients who developed clinical signs of IIH following the surgical treatment of SIH.
The search for (a) and (b) was confined to the years 2014–2020 and conducted in the Radiology Information System (RIS) and Picture Archieving Communication System (PACS) systems using the OPS codes 3-3130 and 2-340 and the terms ‘Zisternographie’ or ‘Enzephalozele’ or ‘Meningoenzephalozele’. The search for (c) was confined to the years 2018–2020, conducted in the RIS and PACS systems using the Operations and Procedure Code (OPS) codes 3-3130 and 2-340 and the term ‘Liquorunterdruck’.
Clinical presentations, diagnostic work-up and therapeutic interventions were taken from the patient’s charts.
MRI signs of IIH were assessed by two neuroradiologists (HU, IED), and different readings were solved in a consensus reading. The following signs were documented: prominent subarachnoid spaces around the optic nerves (see Tables: 1-3), vertical tortuosity of the optic nerves (2), enlarged arachnoid outpouchings with partially empty sella (3a), enlarged Meckel’s cave (3b), prominent arachnoid pits/aberrant arachnoid granulations/small meningoceles typically within the temporal bone and sphenoid wing (3c), enlarged CSF space around the oculomotor nerves in the lateral wall of the cavernous sinus (3d), bilateral venous sinus stenosis or unilateral stenosis and contralateral hypoplasia (4), acquired tonsillar ectopia (mimicking Chiari I malformation) (5).
All procedures in this study were in accordance with 1964 Declaration of Helsinki and its later amendments and proven by the local ethics committee (EK 406/17, 357/20). Informed consent was waived.
Results
Demographic data, imaging work-up and findings, and therapeutic outcomes are summarised in Tables 1–3.
Table 1.
Spontaneous rhinoliquorrhoea.
| No. | Age, gender | BMI/kg/m² | MRI signs of IIH | CSF opening pressure/cm H2O | Diagnostic modality | Diagnosis |
|---|---|---|---|---|---|---|
| 1 | 54, f | 42 | 1, 3a, 3b, 3c, 3d, 4 | – | CT and Magnetic Resonance (MR) cisternography with coronal and axial 3 mm T1-w fat sat sequences | Spontaneous rhinoliquorrhoea with CSF leak at left anterior cribriform plate without bony defect. Recurring leak 3 years later |
| 2 | 83, f | 38 | 3a, 3c | – | CT and MR cisternography with coronal and axial 3 mm T1-w fat sat sequences | Spontaneous rhinoliquorrhoea with anterior temporal encephalocele and bony defect extending into the lateral recess of sphenoid sinus. Persisting rhinoliquorrhoea at left cribriform plate |
| 3 | 55, f | 24 | 1, 3a, 4 | 33 | CT and MRI cisternography with CSSPACE | Spontaneous rhinoliquorrhoea with CSF leak at left anterior cribriform plate without bony defect |
| 4 | 60, f | 32.3 | 1, 3a, 3b, 3c, 4, 5 | – | CT and MRI cisternography with CSSPACE | Spontaneous rhinoliquorrhoea with CSF leak at left cribriform plate with bony defect |
| 5 | 69, f | 24.7 | 3c | – | CT and MRI cisternography with CSSPACE | Spontaneous rhinoliquorrhoea due to CSF leak at right cribriform plate |
| 69, f | 24.7 | 3c | – | CT and MRI cisternography with CSSPACE | Recurring leak after surgical repair of a CSF-leak right cribriform plate | |
| 6 | 46, m | 27.2 | 3b, 3c, 3d, 4 | – | CT and MRI cisternography with CSSPACE | Spontaneous rhinoliquorrhoea due to encephalocele and CSF leak at infero-lateral recess of left sphenoid sinus |
BMI: body mass index: CSF: cerebrospinal fluid; CSSPACE: Compressed Sensing Sampling Perfection with Application optimized Contrasts using different flip angle Evolution; CT: computed tomography; f: female; IIH: idiopathic intracranial hypertension; m: male; MRI: magnetic resonance imaging.
Table 2.
Temporal lobe epilepsy (TLE) and meningo-encephaloceles.
| No. | Age, gender | BMI | MRI signs of IIH | Epilepsy syndrome | Diagnostic modality | Diagnosis | Therapy | Outcome/Engel, Wieser (follow-up time) |
|---|---|---|---|---|---|---|---|---|
| 1 | 55, m | 32.2 | 3a, 3b | Dyscognitive and bilateral tonic-clonic seizures since 6 years | MRI, CT skull base | SEEG-proven TLE due to left temporal lobe meningoencephaloceles, 2 left | Resection of temporal pole including the meningoencephalocele | 1A, 1 (52 months) |
| 2 | 21, m | 24.7 | no | Dyscognitive seizures since 3 years | MRI, CT skull base, fMRI, PET-CT, video-EEG-monitoring | TLE due to left temporal pole meningoencephaloceles, 2 left | Resection of the temporal pole including the two meningoencephaloceles | 1A, 1 (48 months) |
| 3 | 35, m | 26.6 | 2, 3a | Dyscognitive seizures and bilateral tonic-clonic seizures since 10 years | MRI, CT skull base, PET-CT, EEG-monitoring | TLE due to left temporal pole meningoencephaloceles 2 left | Resection of the temporal pole including the encephalocele | 3A, 2 (12 months) |
| 4 | 32, f | 24.7 | 1, 2, 3b | Dyscognitive seizures and bilateral tonic-clonic seizures since 10 years | MRI, CT skull base, fMRI, PET-CT, video-EEG-monitoring, | TLE due to left temporal pole meningoencephalocele 2 (1 left, 1 right) | Resection of the left temporal pole including the meningoencephalocele | 1B, 2 (17 months) |
| 5 | 28, m | 30.1 | no | Psychic auras, dyscognitive seizures, and rare bilateral tonic-clonic seizures since 11 years | MRI, CT skull base, fMRI, PET-CT, video-EEG-monitoring | SEEG-proven temporal lobe epilepsy due to left temporal pole meningoencephaloceles 3 (2 left, 1 right) | Resection of the left temporal pole including the meningoencephaloceles | 1A, 1 (24 months) |
| 6 | 47, f | 21.3 | 1, 2, 3a, 3b, 3c, 3f, 4 | Epigastric auras, dyscognitive seizures and bilateral tonic-clonic seizures since 15 years | MRI, CT skull base, PET-CT, video-EEG-monitoring | TLE due to right temporo-polar encephaloceles in the area of multiple temporo-polar bone defects. Multiple (right > left) | Resection of the encephaloceles, the amygdala and the uncus, latero-basal duraplasty with Tachosil | 1A, 1 (56 months) |
| 7 | 16, f | 33.2 | 3b, 4 | Psychic auras and dyscognitive seizures since 4 years | MRI, CT skull base, fMRI, PET-CT, video-EEG-monitoring | TLE due to right temporal encephalocele 1 right | Resection of the temporal pole, removal of the encephalocele and coverage of the temporo-polar skull base defect | 1A, 1 (50 months) |
| 8 | 25, m | 24.3 | no | Epigastric auras, dyscognitive and bilateral tonic-clonic seizures since 1 year | MRI, CT skull base, PET-CT, video-EEG-monitoring | Drug-resistant left TLE with two temporo-polar encephaloceles 2 left | Resection of the left temporal pole including two temporo-polar encephaloceles and resection of the amygdala while sparing the hippocampus | 1A, 1 → 4B, 5 (72 months) |
| 9 | 45, f | 36.2 | 1, 3a, 3c, 4 | Dyscognitive seizures and bilateral tonic-clonic seizures since 15 years | MRI, CT skull base, fMRI, video-EEG-monitoring | SEEG-proven TLE due to left temporo-basal Meningoencephalocele 2 (1 left, 1 right) | Resection of the left tempo-basal cortex and the meningoencephalocele | 3B, 4 (13 months) |
| 10 | 48, f | 41.7 | 1, 3a, 3c, 4 | Somatosensory auras and tonic-clonic seizures since 4 years | MRI, CT skull base, video-EEG-monitoring | SEEG-proven TLE due to right temporal pole Meningoencephalocele 1 right | Resection with removal of right temporal pole, meningoencephalocele and amygdalohippocampectomy | 1A, 1 (34 months) |
| 11 | 43, f | 35.9 | 1, 3a, 3c, 3d, 4 | Dyscognitive and bilateral tonic-clonic seizures since 10 years | MRI, CT skull base, Video-EEG-monitoring, fMRI, PET-CT | SEEG-proven TLE due to the bilateral sphenoidal meningoencephaloceles 2 (1 right, 1 left) | Resection of the left temporal pole and removal of a lateral and medial meningoencephalocele | 1A, 1 (23 months) |
| 12 | 22, m | 28.3 | no | Somatosensory auras, dyscognitive seizures and bilateral tonic-clonic seizures since 2 years | MRI, CT skull base, video-EEG-monitoring, fMRI, PET-CT | TLE due to the right temporal pole meningoencephalocele 1 right | Resection of the right temporal pole as well as the meningoencephalocele | 3B, 2 (12 months) |
| 13 | 49, m | 34.2 | 3c, 3d, 4 | Unspecific auras, epileptic arousals, dyscognitive seizures and bilateral tonic-clonic seizures since 11 years | MRI, CT skull base, video-EEG-monitoring, fMRI, PET-CT | SEEG-proven TLE due to the left temporal pole meningoencephalocele Multiple (left>right) | Resection of the left temporal pole as well as the meningoencephalocele | 4C, 5 (13 months) |
| 14 | 22, m | 26.9 | no | Unspecific auras, dyscognitive seizures and bilateral clonic seizures since 6 years | MRI, CT skull base, video-EEG-monitoring, fMRI, PET-CT | TLE due to the left temporal pole und temporobasal meningoencephaloceles 2 left | Resection of the meningoencephaloceles left temporo-basal and temporo-polar | 1A, 1 (12 months) |
| 15 | 16, m | 21.7 | no | Unspecific auras and dyscognitive seizures since 2 years | MRI, CT skull base, video-EEG-monitoring | TLE due to left temporopolar meningoencephalocele 1 left | Resection of the left temporal pole including the meningoencephalocele | 1A, 1 (3 months) |
BMI: body mass index: CSF: cerebrospinal fluid; CT: computed tomography; EEG: electroencephalography; f: female; fMRI: functional magnetic resonance imaging; IIH: idiopathic intracranial hypertension; m: male; MRI: magnetic resonance imaging; PET: positron emission tomography; SEEG: stereoelectroencephalography.
Table 3.
Rebound intracranial hypertension (RIH).
| BMI | MRI signs of IIH | Diagnosis/CSF opening pressure | RIH symptoms | Treatment | Follow up | |||
|---|---|---|---|---|---|---|---|---|
| 1 | 49, f | 25.4 | – | Leptomeningeal hemosiderosis Cochlea implant device/14 cm | Ventral dural tear Th 7/8 | Headache, blurred vision, double vision, CSF pressure 38 cm H2O | Lumbar drainage of 30 ml CSF Acetazolamide 2× 500 mg/day | Intermittent double vision No follow-up MRI |
| 2 | 47, f | 38.7 | – | SIH/10 cm H2O | Ventral dural tear Th 10/11 | Headache while lying | Acetazolamide 3× 250 mg/day for 2 weeks | Resolution of RIH symptoms No follow-up MRI |
| 3 | 64, f | 25.3 | – | Leptomeningeal hemosiderosis/17 cm H2O | Ventral dural tear Th 2/3 | Headache while lying dizziness | Acetazolamide 3× 250 mg/day for 1 week | Resolution of RIH symptoms MRI: resolution of SIH signs, no IIH signs |
| 4 | 39, m | 44.6 | 1, 3a, 3d | SIH/punctio sicca | Ventral dural tear Th 1/2 | Headache while lying | Acetazolamide 3× 250 mg/day for 1 week | Resolution of RIH symptoms MRI: Discrete IIH signs |
| 5 | 35, f | 33.6 | 1, 3a, 4 | SIH/16 cm H2O | Ventral dural tear Th 1/2 | Headaches while lying papilledema left | Acetazolamide 3× 250 mg/day for 1 week | Resolution of RIH symptoms MRI: IIH signs |
| 6 | 66, m | 27.5 | 1 | SIH with frontotemporal brain sagging syndrome/4 cm H2O | CSF venous fistula Th 9/10 right | Dizziness, vertigo | Acetazolamide 2× 500 mg/day for 3 months | Marked improvement of SIH symptoms, residual hypacusis MRI: marked improvement of SIH signs, no IIH signs |
| 7 | 41, f | 23.3 | 3a | SIH/2 cm H2O | Ventral dural tear Th 1/2 | Headache while lying dizziness 27 cm H2O | Acetazolamide 3× 250 mg/day for 1 week | Resolution of RIH symptoms MRI: IIH signs |
BMI: body mass index: CSF: cerebrospinal fluid; f: female; IIH: idiopathic intracranial hypertension; m: male; MRI: magnetic resonance imaging; SIH: spontaneous intracranial hypotension.
Spontaneous rhinoliquorrhoea
A total of six patients underwent computed tomography (CT) and MRI cisternography in order to locate an intracranial CSF leak. Three patients each were studied with fat-saturated 2D T1-weighted spin echo sequences (slice thickness 3 mm) or with almost isotropic sagittal T1-weighted black-blood and fat-saturated compressed sensing 3D Sampling Perfection with Application optimized Contrasts using different flip angle Evolution (SPACE) sequences (slice thickness 0.5 mm).14–19 Note that a part of this cohort has been described previously. 19
Four of six patients with spontaneous rhinoliquorrhoea showed MRI signs of IIH and three patients (all women) were obese with a body mass index (BMI) >30 kg/m2 (Figure 1). Of note, in one obese woman, rhinoliquorrhoea recurred after 3 years (Table 1: No. 1), in two women with obesity (Table 1: No. 2) or overweight (Table 1: Np. 5), surgical repair of a cribiform plate leak had to be performed twice.
Figure 1.
Sagittal (a) and axial (d) T2-SPACE images in a 54-year-old obese woman (body mass index (BMI) 42 kg/m2) with partially empty sella ((a): arrow) and protrusions of the subarachnoid space on the left side ((d): arrow). Note that these arachnoid pits are visualised in a skull base-computed tomography (CT) ((f): arrow). Gadolinium-enhanced ((b) and (e)) better than CT cisternography (c) shows a low lying cribiform plate (Keros type 3) and a leak on the left side ((b) and (c): arrow). The leak was surgically treated via a bifrontal approach. Rhinoliquorrhoea was initially stopped but recurred three years later.
Antero-inferior temporal lobe meningoencephaloceles
A total of 15 patients undergoing presurgical work-up for TLE and suspected meningo-encephaloceles were finally operated on. Note that a part of this cohort has been described previously. 7 In six patients, epileptogenicity of a meningo-encephalocele was proven by stereoelectroencephalography (SEEG) (Figure 2). Seven of 15 (47%) patients had a BMI>30 kg/m2 and six patients also showed MRI signs of IIH (40%). Postsurgical seizure freedom (Engel 1A, Wieser 1) after a period of 3–52 months was reached in 10 patients (66.6%) irrespective of BMI, MRI signs of IIH or uni- or bilateral meningo-encephaloceles (Table 2).
Figure 2.
A 48-year-old obese woman (body mass index (BMI) 41.7 kg/m2) suffered from temporal lobe seizures since 4 years. Stereoelectroencephalography (SEEG) recordings from 10 depth electrodes showed a seizure origin in the right-sided anterior temporal lobe. Magnetic resonance imaging (MRI) with coronal T2-weighted turbo spin echo (TSE) images showed a small meningocele ((b): arrow) which resulted in two pits in the skull base computed tomography (CT) ((a): arrow). The patient was treated with anterior temporal lobectomy and amygdalophippocampectomy, the small meningocele was disconnected ((c): arrow). Three years later was seizure-free. Other idiopathic intracranial hypertension (IIH) signs such as empty sella ((d): arrow) or the protrusion of an arachnoid into the transverse sinus remained constant ((e) and (f): arrow)
RIH
A total of 162 patients with symptoms suggestive of SIH underwent a standardised work-up including MRI head, MRI spine, dynamic myelography, CT myelography and in patients with confirmed extrathecal contrast dynamic CT myelography and/or dynamic subtraction myelography, respectively. 20 Forty-four patients finally underwent surgery: In seven patients (16%) with a ventral leak confirmed by surgery (n = 6) or with a CSF venous fistula (n = 1) the headache type changed immediately after surgery. Headache occurred while lying down and was accompanied by dizziness in four patients. Acetazolamide (250 mg three times a day) was prescribed for 1–2 weeks which led to the resolution of symptoms in all patients. MRI was performed in the further follow-up in five patients and showed IIH signs in two patients (Figure 3). Three patients had a BMI>30 kg/m2 (Table 3).
Figure 3.
Rebound intracranial hypertension (RIH) in a 35-year-old, obese woman (body mass index (BMI) 33.6 kg/m2) in which a ventral dural tear at the level Th1/2 was surgically ligated. After surgery she complained of headache while lying down, fundoscopy showed a papilloedema of the left eye. (a)–(c) are images before, (d)–(f) images 2 months after surgery. At this time, RIH symptoms had already resolved. Note a partial empty sella with compression of the pituitary gland anteriorly to the pituitary stalk ((d): arrow) compared to an enlarged (hyperaemic) gland before ((a): arrow). The perioptic cerebrospinal fluid (CSF) spaces are now enlarged ((e): arrows), and the transverse sinus is distinctly smaller ((c) and (f): arrow).
Discussion
The annual incidence of IIH in industrialised countries is strongly increasing: From 1.0/100.000 in 1990, 2.3/100.000 in 2003 to 7.8/100.000 in 2017. 19 , 22 The incidence may be even higher when patients presenting with spontaneous CSF rhinorrhoea, TLE due to temporal lobe meningo-encephaloceles or RIH are considered. These patients do not complain of headaches, transient visual obscurations, and/or visual loss or blurring, and it is rather the MRI findings that are suggestive of the diagnosis of IIH. However, as imaging is typically adapted to the specific clinical presentation, relevant MRI sequences such as MR venography to prove transverse sinus stenosis are not acquired. Moreover, the CSF pressure is rarely measured.
Patients with spontaneous rhinoliquorrhoea
For evaluating patients with suspected intracranial CSF leaks the most widely accepted method is CT cisternography. As adjacent bony structures and contrast-enhanced CSF have similar density values intrathecal injection of gadolinium although not Food and Drug Administration (FDA)-approved (Figure 1) is a valuable alternative.14–19 Gadolinium cisternography provides a high contrast between bony structures, air cell structures, and CSF diluted with gadolinium as well as a high spatial resolution when a T1-weighted sequence with an almost isotropic 3D resolution (0.5 × 0.5 × 0.6 mm3) is acquired. 19 All patients in this series have been studied with CT and MR cisternography: Three of six patients with spontaneous rhinoliquorrhoea but none of five patients with iatrogenic rhinoliquorrhoea studied in the same period showed MRI signs of IIH. Three of six patients had a BMI>30 kg/m2 indicating that IIH promotes the development of spontaneous intracranial CSF leaks.
Patients with temporal lobe meningo-encephaloceles
That antero-inferior temporal lobe meningo-encephaloceles can cause TLE has been described with larger series since 2015 (Figure 2).7–11 The prevalence of temporal lobe meningo-encephaloceles causing TLE is in the range of 5–10%. 23 However, the definition of a meningo-encephalocele is not straightforward. Encephaloceles are protrusions of brain through focal bony defects. Meningoceles are focal bony dehiscences containing CSF but not brain parenchyma. They likely represent arachnoid granulations protruding into the overlying bone. The number and size of arachnoid granulations are larger in IIH patients compared to controls, however so-called arachnoid pits are found in 20% and temporal lobe encephaloceles in 5% of asymptomatic controls, respectively.24–26 In this series, we only analysed operated patients, in six patients the epileptogenicity of an encephalocele was proven with SEEG. Nine of 15 patients (60%) showed MRI signs of IIH, seven patients (44%) had a BMI>30 kg/m2 and six had both of these again emphasising the correlation between IIH and obesity in some, but not all, patients.
Patients with spontaneous rhinorrhoea often also have temporal lobe meningo-encephaloceles (Figure 1). Why some patients with MRI signs of IIH develop TLE, others rhinoliquorrhoea and others classical IIH symptoms has been explained with the glymphatic system allowing to drain the CSF along paravascular channels of the optic nerve sheaths more effectively in older than in younger patients.27–30 Of clinical note is that rhinoliquorrhoea may persist or recur when the underlying cause IIH is not sufficiently treated. 28 And epileptic seizures originating from the contralateral temporal pole may arise when one meningo-encephalocele is disconnected. As bilateral lesions are present in 30–40% of cases, 7 , 8 , 26 this could imply to also treat the IIH. 31
Female gender and obesity are accepted risk factors for IIH. Weight reduction by low-calorie meal replacement or even bariatic surgery may improve classical symptoms such as headaches and vision.32–34 Whether these are helpful following the surgical closure of a spontaneous CSF leak (to avoid a recurring leak) or in TLE patients due to encephaloceles (to reduce seizures) remains to be proven.
The pathological mechanisms that link female gender, obesity, and IIH are unclear, as IIH is relatively rare, while obesity is common. That centrally distributed adiposity transmits pressure and thereby generates raised Intracranial Pressure (ICP) is questionable, as few obese patients have elevated ICP. Hormonal mechanisms and dysregulation of adipokines and cytokines are pathogenic in dysregulating ICP, the latter, however may merely be a consequence of the disease.35–37
Patients with rebound intracranial hypertension (RIH)
RIH following treatment of SIH was first reported in 1996 in a patient who underwent surgical repair of a leaking thoracic meningeal diverticulum. 33 RIH is defined as a different headache form (‘reverse orthostatic headache’) responsive to acetazolamide. The most common scenario is that a (sub)occipital SIH headache transforms to a frontal high-pressure headache. 12 , 13 Most patients also have new nausea and/or vomiting and complain of new blurred vision. 13
RIH occurs in about one-quarter of patients following treatment of SIH, most often within 72 h but in rare cases up to 1 month following treatment. RIH occurs more often in women, at a younger age, and when imaging shows extradural CSF, possibly reflecting the severity of the underlying spinal CSF leak and the potential for significant shifts in CSF dynamics following treatment. 12 Funduscopic examination shows papilloedema in a minority of patients only, CSF pressure is often between 20–25 cm H2O, but distinctly higher than before treatment. 12
While SIH patients typically have a low BMI, it is interesting to note that three patients in our RIH group had a BMI>30 kg/m2. 38
Imaging findings have rarely been described in RIH patients. 12 However, as it is a diagnostic criterion in IIH it may also help to support the diagnosis RIH (Figure 3).
Conclusions
We have described less widely known entities that can present with MRI signs of IIH. MRI findings should guide the clinician to consider IIH when patients develop spontaneous rhinoliquorrhoea or TLE due to temporal lobe meningo-encephaloceles. Further work has to be done to elucidate why and which SIH patients develop RIH.
Footnotes
Conflict of interest: The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
Funding: The author(s) received no financial support for the research, authorship and/or publication of this article.
ORCID iDs: H Urbach https://orcid.org/0000-0001-7264-4807
References
- 1.Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia 2018; 38: 1–211. [DOI] [PubMed] [Google Scholar]
- 2.Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2013; 81: 1159–1665. [DOI] [PubMed] [Google Scholar]
- 3.Hoffmann J, Schmidt C, Kunte H, et al. Volumetric assessment of optic nerve sheath and hypophysis in idiopathic intracranial hypertension. AJNR Am J Neuroradiol 2014; 35: 513–518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Guliyeva A, Apaydin M, Beckmann Y, et al. Migraine or idiopathic intracranial hypertension: Magnetic resonance venography and magnetic resonance imaging findings. Neuroradiol J 2020. 33: 244–251. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Prabhat N, Chandel S, Takkar DA, et al. Sensitivity and specificity of neuroimaging signs in patients with idiopathic intracranial hypertension. Neuroradiol J. Epub ahead of print 8 March 2021. DOI: 10.1177/19714009211000623. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Alonso RC, de la Peña MJ, Caicoya AG, et al. Spontaneous skull base meningoencephaloceles and cerebrospinal fluid fistulas. Radiographics 2013; 33: 553–570. [DOI] [PubMed] [Google Scholar]
- 7.Urbach H, Jamneala G, Mader I, et al. Temporal lobe epilepsy due to meningoencephaloceles into the greater sphenoid wing: A consequence of idiopathic intracranial hypertension? Neuroradiology 2018; 60: 51–60. [DOI] [PubMed] [Google Scholar]
- 8.Campbell ZM, Hyer JM, Lauzon S, et al. Detection and characteristics of temporal encephaloceles in patients with refractory epilepsy. AJNR Am J Neuroradiol 2018; 39: 1468–1472. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Paule E, Freiman TM, Strzelczyk A, et al. Characteristics of bilateral versus unilateral temporal encephalocele-associated epilepsy. Seizure 2019; 71: 13–19. [DOI] [PubMed] [Google Scholar]
- 10.Martinez-Poles J, Toldedano R, Jiménez-Heute A, et al. Epilepsy associated with temporal pole encephaloceles: An unrecognized manifestation of idiopathic intracranial hypertension? Clin Neuroradiol. Epub ahead of print 15 October 2020. DOI: 10.1007/s00062-020-00969-0. [DOI] [PubMed] [Google Scholar]
- 11.Tse GT, Frydman AS, O’Shea M, et al. Anterior temporal encephaloceles: Elusive, important, and rewarding to treat. Epilepsia 2020; 61: 2675–2684. [DOI] [PubMed] [Google Scholar]
- 12.Schievink WI, Maya MM, Jean-Pierre S, et al. Rebound high-pressure headache after treatment of spontaneous intracranial hypotension: MRV study. Neurol Clin Pract 2019; 9: 93–100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Kranz PG, Amrhein TJ, Gray L. Rebound intracranial hypertension: A complication of epidural blood patching for intracranial hypotension. AJNR Am J Neuroradiol 2014; 35: 1237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Aydin K, Guven K, Sencer S, et al. MRI cisternography with gadolinium-containing contrast medium: Its role, advantages and limitations in the investigation of rhinorrhea. Neuroradiology 2004; 46: 75–80. [DOI] [PubMed] [Google Scholar]
- 15.Jinkins JR, Rudwan M, Krumina G, et al. Intrathecal gadolinium enhanced MR cisternography in the evaluation of clinically suspected cerebrospinal fluid rhinorrhea in humans: Early experience. Radiology 2002; 222: 555–559. [DOI] [PubMed] [Google Scholar]
- 16.Selcuk H, Albayran S, Ozer H, et al. Intrathecal gadolinium-enhanced MR cisternography in the evaluation of CSF leakage. AJNR Am J Neuroradiol 2010; 31: 71–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Zhu C, Tian B, Chen L, et al. Accelerated whole brain intracranial vessel wall imaging using black blood fast spin echo with compressed sensing (CS-SPACE). MAGMA 2018; 31(3): 457–467. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Guggenberger K, Krafft AJ, Ludwig U, et al. High-resolution compressed-sensing T1 black-blood MRI: A new multipurpose sequence in vascular neuroimaging? Clin Neuroradiol. Epub 2019 Dec 18. 2019. DOI: 10.1007/s00062-019-00867-0 [DOI] [PubMed] [Google Scholar]
- 19.Duman IE, Demerath T, Stadler A, et al. High-resolution gadolinium-enhanced MR cisternography using compressed-sensing (CS) T1 SPACE technique for detection of intracranial CSF leaks. AJNR Am J Neuroradiol. Epub ahead of print 29 October 2020. doi: 10.3174/ajnr.A6852 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Urbach H, Fung C, Dovi-Akue P, et al. Spontaneous intracranial hypotension—presentation, diagnosis and treatment. Dtsch Arztebl Int 2020; 117: 480–487. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Radhakrishnan K, Ahlskog JE, Cross SA, et al. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol 1993; 50: 78–80. [DOI] [PubMed] [Google Scholar]
- 22.Miah L, Strafford H, Fonferko-Shadrach B, et al. Incidence, prevalence and healthcare outcomes in idiopathic intracranial hypertension: A population study. Neurology. Epub before print 20 January 2021. DOI: 10.1212/WNL.0000000000011463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Gasparini S, Ferlazzo E, Pustorino G, et al. Epileptogenic role of occult temporal encephalomeningocele: Case-control study. Neurology 2018; 90: e1200–e1203. [DOI] [PubMed] [Google Scholar]
- 24.Settecase F, Harnsberger HR, Michel MA, et al. Spontaneous lateral sphenoid cephaloceles: Anatomic factors contributing to pathogenesis and proposed classification. AJNR Am J Neuroradiol 2014; 35: 784–789. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Watane GV, Patel B, Brown D, et al. The significance of arachnoid granulation in patients with idiopathic intracranial hypertension. J Comput Assist Tomogr 2018; 42: 282–285. [DOI] [PubMed] [Google Scholar]
- 26.Benson JC, Lane J, Geske JR, et al. Prevalence of asymptomatic middle cranial fossa floor pits and encephaloceles on MR imaging. AJNR Am J Neuroradiol 2019; 40: 2090–2093. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Bezerra MLS, Ferreira ACAF, de Oliveira-Souza R. Pseudotumor cerebri and glymphatic dysfunction. Front Neurol 2018; 8: 734. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Denniston AK, Keane PA, Aojula A, et al. The ocular glymphatic system and idiopathic intracranial hypertension: Author response to ‘hypodense holes and the ocular glymphatic system’. Invest Ophthalmol Vis Sci 2017; 58: 1134–1136. [DOI] [PubMed] [Google Scholar]
- 29.Lenck S, Radovanovic I, Nicholson P, et al. Idiopathic intracranial hypertension: The venoglympathic connections. Neurology 2018; 91: 515–522. [DOI] [PubMed] [Google Scholar]
- 30.Pérez MA, Bialer OY, Bruce BB, et al. Primary spontaneous cerebrospinal fluid leaks and idiopathic intracranial hypertension. J Neuroophthalmol 2013; 33: 330–337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Kenning TJ , Willcox TO, Artz GJ, et al. Surgical management of temporal meningoencephaloceles, cerebrospinal fluid leaks, and intracranial hypertension: Treatment paradigm and outcomes. Neurosurg Focus 2012; 32: E6. [DOI] [PubMed] [Google Scholar]
- 32.Johnson LN, Krohel GB, Madsen RW, et al. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 1998; 105: 2313–2317. [DOI] [PubMed] [Google Scholar]
- 33.Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: Prospective cohort study. BMJ 2010; 341: c270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Nadkarni T, Rekate HR, Wallace D. Resolution of pseudotumor cerebri after bariatric surgery for related obesity. Case report. J Neurosurg 2004; 101: 878–880. [DOI] [PubMed] [Google Scholar]
- 35.Mollan SP, Ali F, Hassan-Smith G, et al. Evolving evidence in adult idiopathic intracranial hypertension: Pathophysiology and management. J Neurol Neurosurg Psychiatry 2016; 87: 982–992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Markey KA, Mollan SP, Jensen RH, et al. Understanding idiopathic intracranial hypertension: Mechanisms, management, and future directions. Lancet Neurol 2016; 15: 78–91. [DOI] [PubMed] [Google Scholar]
- 37.Schievink WI, Meyer FB, Atkinson JL, et al. Spontaneous spinal cerebrospinal fluid leaks and intracranial hypotension. J Neurosurg 1996; 84: 598–605. [DOI] [PubMed] [Google Scholar]
- 38.Rosebrock RE, Diehn FE, Luetmer PH, et al. Penetrating osseous spicules causing high-flow ventral CSF leaks in the setting of relatively low BMI: A preliminary study. Clin Neuroradiol 2018; 28: 539–543. [DOI] [PubMed] [Google Scholar]



